Endometrial Cancer | Topics

Dostarlimab Shows Promising Antitumor Activity in Mismatch Repair Deficient, Proficient Endometrial Cancer
September 20, 2020

“Dostarlimab demonstrated durable antitumor activity in both dMMR and MMRp advanced and recurrent endometrial cancer,” said Ana Oaknin, MD, PhD.

LY3023414 Demonstrates Manageable Safety Profile in Patients with Endometrial Cancer
January 26, 2020

The dual PI3K/mTOR inhibitor LY3023414 also displayed moderate single-agent activity in this study of patients with heavily pretreated advanced endometrial cancer.

Engaging in the Recommended Amount of Physical Activity May Help Prevent 7 Cancer Types
January 07, 2020

Though physical activity guidelines are largely based on chronic diseases like cardiovascular disease and diabetes, these data suggest they are important to cancer prevention as well.